India
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
23.63%
|
March 31, 2024 | USD 25.80 | 12.75% |
|
India |
|
2 |
17.12%
|
March 31, 2024 | USD 11.90 | 11.12% |
|
India |
|
3 |
15.10%
|
March 31, 2024 | USD 13.60 | -0.27% |
|
India |
|
4 |
10.49%
|
March 31, 2024 | USD 21.80 | 0.20% |
|
India |
|
5 |
0.31%
|
March 31, 2024 | USD 17.12 | 0.17% |
|
India |
|
6 |
0.26%
|
March 31, 2024 | USD 4.90 | 9.41% |
|
India |
|
7 |
-15.06%
|
March 31, 2024 | USD 18.85 | -0.37% |
|
India |
The Vaccines company in India with the highest EBT Margin is GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO.NS) at 23.63%.
The Vaccines company in India with the lowest EBT Margin is Wockhardt Limited (NSE: WOCKPHARMA.NS) at -15.06%.
The top 10 Vaccines companies in India by EBT Margin are GlaxoSmithKline Pharmaceuticals Limited, Vimta Labs Limited, Aurobindo Pharma Limited, Hester Biosciences Limited, Glenmark Pharmaceuticals Limited, Panacea Biotec Limited and Wockhardt Limited.
The bottom 10 Vaccines companies in India by EBT Margin are Wockhardt Limited, Panacea Biotec Limited, Glenmark Pharmaceuticals Limited, Hester Biosciences Limited, Aurobindo Pharma Limited, Vimta Labs Limited and GlaxoSmithKline Pharmaceuticals Limited.